Magnolia Capital Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$437K Buy
15,560
+2,848
+22% +$75.8K 0.09% 214
2025
Q4
$317K Buy
12,712
+2,429
+24% +$61.3K 0.07% 229
2025
Q3
$262K Sell
10,283
-734
-7% -$18.1K 0.07% 205
2025
Q2
$267K Buy
11,017
+248
+2% +$5.78K 0.07% 205
2025
Q1
$273K Sell
10,769
-9,652
-47% -$253K 0.07% 199
2024
Q4
$542K Buy
20,421
+11,975
+142% +$325K 0.14% 153
2024
Q3
$244K Buy
+8,446
New +$246K 0.12% 128
2023
Q3
Sell
-12,390
Closed -$454K 121
2023
Q2
$454K Buy
12,390
+283
+2% +$11K 0.23% 89
2023
Q1
$494K Sell
12,107
-200
-2% -$8.64K 0.25% 94
2022
Q4
$631K Buy
12,307
+172
+1% +$8.25K 0.42% 68
2022
Q3
$531K Sell
12,135
-1,380
-10% -$67.1K 0.45% 64
2022
Q2
$708K Sell
13,515
-1,299
-9% -$66.2K 0.64% 53
2022
Q1
$767K Buy
14,814
+201
+1% +$10.4K 0.3% 88
2021
Q4
$863K Buy
14,613
+805
+6% +$39.9K 0.25% 80
2021
Q3
$594K Sell
13,808
-1,564
-10% -$69.3K 0.21% 97
2021
Q2
$602K Buy
+15,372
New +$598K 0.27% 71
2021
Q1
Sell
-13,396
Closed -$493K 113
2020
Q4
$493K Sell
13,396
-581
-4% -$21.3K 0.32% 52
2020
Q3
$487K Sell
13,977
-852
-6% -$29.9K 0.38% 44
2020
Q2
$460K Sell
14,829
-4,399
-23% -$149K 0.59% 32
2020
Q1
$595K Buy
19,228
+1,503
+8% +$51.2K 1.15% 23
2019
Q4
$658K Buy
+17,725
New +$631K 0.63% 30

Other funds holding PFE

Magnolia Capital Advisors's PFE Position: Q1 2026 in Review

Magnolia Capital Advisors increased its Pfizer (PFE) stake by 22% in Q1 2026, buying an estimated $75.8K and bringing the position to 15,560 shares worth $437K. The position accounts for 0.09% of the portfolio, ranked #214.

Magnolia Capital Advisors first reported a position in PFE in Q4 2019 and has held it in 21 quarters since. The position peaked at $863K in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Magnolia Capital Advisors held 15,560 shares of Pfizer worth $437K as of Q1 2026.
  • Magnolia Capital Advisors bought 2,848 Pfizer shares in Q1 2026, an estimated $75.8K.
  • Pfizer made up 0.09% of Magnolia Capital Advisors's portfolio in Q1 2026, its #214 holding.
  • Magnolia Capital Advisors first reported a position in Pfizer in Q4 2019 and has held it in 21 quarters since.
  • Magnolia Capital Advisors's Pfizer position peaked at $863K in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Magnolia Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.